Skip to main content
. 2010 Jan 20;2010(1):CD008285. doi: 10.1002/14651858.CD008285

Whitney 1999.

Methods RCT
1986 to 1990
Participants 388 patients
Stage IIB to IVA
Interventions Radiotherapy plus hydroxyurea versus concomitant chemoradiotherapy (cisplatin, 5FU)
Outcomes Survival, disease‐free survival, local and distant recurrence,acute toxicity
Notes Only included in the sensitivity analysis due to use of additional hydroxyurea on the control arm only
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Data checks on IPD provided suggest adequate sequence generation
Blinding (performance bias and detection bias) 
 All outcomes High risk Trial was not blinded due to nature of treatment interventions
Incomplete outcome data (attrition bias) 
 All outcomes Low risk IPD provided for all outcomes except late toxicity
Selective reporting (reporting bias) Low risk N/A (IPD supplied for all outcomes except late toxicity)
Other bias Low risk Data checks on IPD provided suggest study is free of follow‐up bias